Semaglutide Alternatives & Comparison
Semaglutide (semaglutide) set beside Tirzepatide, Saxenda, Foundayo: how each works, what its trials measured, what it costs, and who sells it.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
These are the drugs people weigh against Semaglutide. The Semaglutide drug guide covers Semaglutide itself, the Semaglutide cost page covers its price, and the Semaglutide how-to-get page covers the routes to a prescription.
Semaglutide Alternatives Compared
Adds GIP to the GLP-1 action, and head-to-head trials generally show more average weight loss
Tirzepatide is a "twincretin". Two incretin receptors switch on together under it: GLP-1, and GIP — glucose-dependent insulinotropic polypeptide.
In the SURMOUNT-1 trial (N=2,539), tirzepatide at the 15mg dose achieved an average weight loss of 20.9% over 72 weeks.
A daily GLP-1 injection that has been around longer, if track record is what you weigh
Liraglutide is an acylated, 97%-homologous analog of native human GLP-1, modified with a fatty-acid side chain that lets it bind albumin and resist DPP-4 degradation — extending its half-life from minutes to about 13 hours.
The pivotal trial was SCALE Obesity and Prediabetes (N=3,731 adults, none diabetic; Pi-Sunyer et al. NEJM 2015, PMID 26132939).
Daily pill, different molecule, and nothing to inject
Orforglipron is not built as a peptide. It is a small organic molecule that binds the GLP-1 receptor and switches it on directly.
ATTAIN-1 (NCT05869903; Wharton et al.
An oral drug outside the GLP-1 class, which matters if incretin GI effects are the problem
Bupropion stimulates hypothalamic pro-opiomelanocortin (POMC) neurons, which release alpha-MSH to reduce appetite, but POMC neurons also release beta-endorphin, which feeds back onto mu-opioid receptors on the POMC neurons themselves and shuts them off — limiting the appetite-suppressing effect.
Contrave's FDA approval was supported by four pivotal 56-week phase 3 trials in the Contrave Obesity Research (COR) program.
Drug facts on this page were last verified against each drug's FDA label and trial record.
Compare compounded Semaglutide providers
Compounded semaglutide sits at a middle figure of $199/month across 726 price points in the register, spanning $49 to $599. The partners below are ordered by our partner economics.
Compare compounded Tirzepatide providers
Compounded tirzepatide sits at a middle figure of $250/month across 697 price points in the register, spanning $69 to $849. The partners below are ordered by our partner economics.
Compare every Semaglutide provider
Current price, verification status, product form and the states each seller ships to, all on one screen.